Ociperlimab Active Not Recruiting Phase 2 Trials for Stage IV Non-small Cell Lung Cancer (NSCLC) / Locally Advanced, Unresectable, or Metastatic Nonsmall Cell Lung Cancer (NSCLC) Treatment

Indications	Status	Purpose	Phase
DBCOND0122752 (Stage IV Non-small Cell Lung Cancer (NSCLC)) DBCOND0149116 (Locally Advanced, Unresectable, or Metastatic Nonsmall Cell Lung Cancer (NSCLC))	Active Not Recruiting	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT05014815	Ociperlimab With Tislelizumab and Chemotherapy in Participants With Untreated Metastatic Non-Small Cell Lung Cancer	Ociperlimab (DB18947) Tislelizumab (DB14922)